Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats.

Salvati S, Di Biase A, Attorri L, Di Benedetto R, Sanchez M, Lorenzini L, Alessandri M, Calzà L.

J Nutr Biochem. 2013 Sep;24(9):1645-54. doi: 10.1016/j.jnutbio.2013.02.005. Epub 2013 May 1.

PMID:
23642735
2.

Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feeding.

Di Biase A, Salvati S, Di Benedetto R, Attorri L, Martinelli A, Malchiodi F.

Prostaglandins Leukot Essent Fatty Acids. 2014 Apr;90(4):99-104. doi: 10.1016/j.plefa.2013.11.004. Epub 2013 Dec 7.

PMID:
24360206
3.

High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.

Blaževski J, Petković F, Momčilović M, Jevtic B, Miljković D, Mostarica Stojković M.

Immunobiology. 2013 Sep;218(9):1192-9. doi: 10.1016/j.imbio.2013.04.004. Epub 2013 Apr 12.

PMID:
23664544
4.

Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.

Castelo-Branco G, Stridh P, Guerreiro-Cacais AO, Adzemovic MZ, Falcão AM, Marta M, Berglund R, Gillett A, Hamza KH, Lassmann H, Hermanson O, Jagodic M.

Neurobiol Dis. 2014 Nov;71:220-33. doi: 10.1016/j.nbd.2014.08.019. Epub 2014 Aug 19.

5.

Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.

Castro SB, Junior CO, Alves CC, Dias AT, Alves LL, Mazzoccoli L, Mesquita FP, Figueiredo NS, Juliano MA, Castañon MC, Gameiro J, Almeida MV, Teixeira HC, Ferreira AP.

Int Immunopharmacol. 2012 Feb;12(2):465-70. doi: 10.1016/j.intimp.2011.12.025. Epub 2012 Jan 13.

7.

Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.

Meng L, Ouyang J, Zhang H, Wen Y, Chen J, Zhou J.

Restor Neurol Neurosci. 2011;29(3):177-85. doi: 10.3233/RNN-2011-0590.

PMID:
21586824
8.

LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.

Duplan V, Beriou G, Heslan JM, Bruand C, Dutartre P, Mars LT, Liblau RS, Cuturi MC, Saoudi A.

J Immunol. 2006 Jan 15;176(2):839-47.

9.

The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.

Karussis D, Abramsky O, Grigoriadis N, Chapman J, Mizrachi-Koll R, Niv H, Kloog Y.

J Neuroimmunol. 2001 Nov 1;120(1-2):1-9.

PMID:
11694313
10.
11.

Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.

Donia M, Mangano K, Amoroso A, Mazzarino MC, Imbesi R, Castrogiovanni P, Coco M, Meroni P, Nicoletti F.

J Autoimmun. 2009 Sep;33(2):135-40. doi: 10.1016/j.jaut.2009.06.003. Epub 2009 Jul 21.

PMID:
19625166
12.

Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin.

Stosic-Grujicic S, Savic-Radojevic A, Maksimovic-Ivanic D, Markovic M, Bumbasirevic V, Ramic Z, Mostarica-Stojkovic M.

J Neuroimmunol. 2002 Sep;130(1-2):66-77.

PMID:
12225889
14.

Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.

Unoda K, Doi Y, Nakajima H, Yamane K, Hosokawa T, Ishida S, Kimura F, Hanafusa T.

J Neuroimmunol. 2013 Mar 15;256(1-2):7-12. doi: 10.1016/j.jneuroim.2012.12.003. Epub 2012 Dec 28.

PMID:
23276800
15.

FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.

Papadopoulos D, Rundle J, Patel R, Marshall I, Stretton J, Eaton R, Richardson JC, Gonzalez MI, Philpott KL, Reynolds R.

J Neurosci Res. 2010 Feb 1;88(2):346-59. doi: 10.1002/jnr.22196.

PMID:
19658199
16.

Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.

Yin LL, Lin LL, Zhang L, Li L.

Neuropharmacology. 2012 Oct;63(5):851-62. doi: 10.1016/j.neuropharm.2012.06.025. Epub 2012 Jun 21.

PMID:
22728315
17.

[Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].

Devaux J, Beeton C, Béraud E, Crest M.

Rev Neurol (Paris). 2004 May;160(5 Pt 2):S16-27. French.

PMID:
15269656
18.
19.

Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.

Phillips SM, Bhopale MK, Constantinescu CS, Ciric B, Hilliard B, Ventura E, Lavi E, Rostami A.

J Neurol Sci. 2007 Dec 15;263(1-2):59-69. Epub 2007 Jul 2.

PMID:
17603081
20.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.

Supplemental Content

Support Center